NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
SSMOX
Price
$12.34
Change
-$0.01 (-0.08%)
Updated
Jul 31 closing price
Net Assets
194.63M
Interact to see
Advertisement

NAESX vs SSMOX

NAESX vs SSMOX Comparison Chart in %
View a ticker or compare two or three
VS
NAESX vs. SSMOX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a Hold and SSMOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. SSMOX (195M). NAESX pays higher dividends than SSMOX: NAESX (1.10) vs SSMOX (0.93). NAESX was incepted earlier than SSMOX: NAESX (66 years) vs SSMOX (9 years). SSMOX (0.53) is less costly to investors than NAESX (0.17). SSMOX is a more actively managed with annual turnover of: 36.00 vs. NAESX (17.00). NAESX (0) and SSMOX (0) have matching initial minimum investment requirements. NAESX annual gain was more profitable for investors over the last year : 22.56 vs. SSMOX (13.48). NAESX return over 5 years is better than : 34.95 vs. SSMOX (-21.01).
NAESXSSMOXNAESX / SSMOX
Total Expense Ratio0.170.5332%
Annual Report Gross Expense Ratio0.170.5332%
Fund Existence66 years9 years-
Gain YTD14.56315.86992%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets189B195M96,923%
Annual Yield % from dividends1.100.93119%
Returns for 1 year22.5613.48167%
Returns for 3 years43.3016.77258%
Returns for 5 years34.95-21.01-166%
Returns for 10 years155.28N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv